Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations
Dmitri Mouradov, Enric Domingo, Peter Gibbs, Robert N Jorissen, Shan Li, Pik Ying Soo, Lara Lipton, Jayesh Desai, Havard E Danielsen, Dahmane Oukrif, Marco Novelli, Christopher Yau, Christopher C Holmes, Ian T Jones, Stephen McLaughlin, Peter Molloy, Nicholas J Hawkins, Robyn Ward, Rachel Midgely, David Kerr Show all
American Journal of Gastroenterology | NATURE PUBLISHING GROUP | Published : 2013
Awarded by NHMRC
Awarded by UK Medical Research Council Specialist Training Fellowship in Biomedical Informatics
Awarded by Cancer Research UK
Awarded by Medical Research Council
Financial support: This work was supported by the Hilton Ludwig Cancer Metastasis Initiative (to O.M.S.), the NHMRC through a Project Grant (Application ID 489418; to L. L., P. M., R. W., O.M.S.), and the Victorian Government through a Victorian Cancer Agency Translation Cancer Research Grant (to P. G., O.M.S.). J.D. is supported by the Victorian Cancer Agency through a Clinical Researcher Fellowship. L. L. is supported by the CSIRO Preventative Health Flagship through a Clinical Researcher Fellowship. Cancer Research UK supported I. T. and the Oxford NIHR Comprehensive Biomedical Research Centre, E. D. The Wellcome Trust Centre for Human Genetics, Oxford is supported by core grant (090532/Z/09/Z). C.Y. is supported by a UK Medical Research Council Specialist Training Fellowship in Biomedical Informatics (Ref. No. G0701810).